Toolbox
Fasting Insulin Interpreter
Your lab says "in range." But in range is not optimal. Enter your fasting insulin to see where you really stand.
Your Fasting Insulin
Most US labs report fasting insulin in μIU/mL. The standard reference range is 2-25 μIU/mL, but optimal targets are stricter.
Enter your most recent fasting insulin result. Standard reference ranges may show readings well above the optimal target as 'in range.'
Medications that may affect your result
Metformin reduces insulin resistance and will lower your fasting insulin level. If you are on metformin, your unmedicated fasting insulin would likely be higher than shown.
Insulin therapy invalidates fasting-insulin interpretation. The test measures endogenous insulin output; exogenous insulin distorts the reading and the downstream HOMA-IR calculation.
Corticosteroids (prednisone, dexamethasone) and some antipsychotics (olanzapine, clozapine) are associated with increased insulin resistance and may elevate fasting insulin independent of underlying baseline.
If you are taking any of these medications, your results reflect the medicated state. Discuss with your healthcare provider for proper context.
About this tool
Formula
Fasting insulin is measured directly from a fasting blood draw, reported in micro-International Units per milliliter (μIU/mL). No formula — the value is read off the lab report.
Classification
Optimal: below 5 μIU/mL. Acceptable: 5-9.99. Borderline (early IR signal): 10-14.99. Elevated (IR likely present): 15 and above. These targets are stricter than the standard lab reference range (2-25 μIU/mL) because 'normal' on a lab report is not 'optimal' for metabolic health — fasting insulin in the 5-15 range typically reflects rising insulin output to compensate for early insulin resistance.
Known Limitations
Requires a true fasting state (8-12 hours, water only). Day-to-day variability of 20-30% is normal — a single measurement is directional, not definitive. Invalid during insulin therapy. Acute stress or illness on the day of the draw can elevate readings. For ethnicity-specific considerations and a fuller picture, pair with HbA1c, HOMA-IR, and TG:HDL ratio from a lipid panel.
Sources
Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988. Kraft JR. Diabetes Epidemic & You. 2008. Various IR-screening protocols (Ascaso, Gayoso-Diz, Kraft).
Educational tool only. Not for diagnostic purposes. Consult a healthcare provider for medical decisions.